We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Influence of Hormone Therapy on Heart Attack Incidence in Men Undergoing Prostate Brachytherapy

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00651222
First Posted: April 2, 2008
Last Update Posted: April 2, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Prostate Cancer Foundation of Chicago
  Purpose
The purpose of this study is to review cause of death in patients undergoing prostate brachytherapy at a single institution. Furthermore, we are analyzing patients undergoing androgen deprivation therapy and whether or not this contributed to cardiovascular deaths, specifically myocardial infarction.

Condition Intervention
Prostate Cancer Cardiovascular Death Other: No intervention was required

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Influence of Androgen Suppression Therapy for Prostate Cancer on the Timing and Onset of Fatal Myocardial Infarctions in Men Undergoing Prostate Brachytherapy

Resource links provided by NLM:


Further study details as provided by Prostate Cancer Foundation of Chicago:

Groups/Cohorts Assigned Interventions
1
All deceased patients who underwent brachytherapy at Chicago Prostate Center between 10/14/1997 and 6/15/2007
Other: No intervention was required
Death records were reviewed, therefore, there was no intervention
Other Name: Death records were reviewed, therefore, there was no intervention

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Prostate cancer patients treated with prostate brachytherapy at an ambulatory surgery center
Criteria

Inclusion Criteria:

  • Deceased anytime after prostate brachytherapy treatment

Exclusion Criteria:

  • Patients whose cause of death was unable to be determined
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00651222


Locations
United States, Illinois
Chicago Prostate Center
Westmont, Illinois, United States, 60559
Sponsors and Collaborators
Prostate Cancer Foundation of Chicago
  More Information

Responsible Party: Brian J. Moran, MD, Prostate Cancer Foundation of Chicago
ClinicalTrials.gov Identifier: NCT00651222     History of Changes
Other Study ID Numbers: MI-PB
First Submitted: March 31, 2008
First Posted: April 2, 2008
Last Update Posted: April 2, 2008
Last Verified: March 2008

Additional relevant MeSH terms:
Prostatic Neoplasms
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Genital Diseases, Male
Prostatic Diseases